<svg xmlns="http://www.w3.org/2000/svg" version="1.1" style="background-color:#fff;-webkit-font-smoothing:antialiased" width="850" height="600" font-family="'Helvetica Neue',Helvetica,Arial,sans-serif" font-size="18" text-rendering="optimizeLegibility"><g class="ChartTab"><g class="HeaderView"><g opacity=".8" transform="matrix(.27 0 0 .27 778 15)"><a xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ourworldindata.org" target="_blank"><g><path fill="#1B2543" d="M0 0h211.2v130.1H0z"/><path fill="#E63912" d="M0 112.2h211.2v17.9H0z"/><g><path fill="none" d="M1.2 12.3h210.2v99.2H1.2z"/><path fill="#FFF" d="M37.8 32.2c0 12.7-7.7 19.4-17.1 19.4-9.7 0-16.6-7.5-16.6-18.7 0-11.7 7.3-19.3 17.1-19.3 10.1.1 16.6 7.7 16.6 18.6zm-28.6.6c0 7.9 4.3 14.9 11.8 14.9 7.5 0 11.8-6.9 11.8-15.3 0-7.3-3.8-14.9-11.8-14.9-7.9 0-11.8 7.3-11.8 15.3zM62.7 43.8c0 2.7.1 5.1.2 7.2h-4.3l-.3-4.3h-.1c-1.3 2.1-4 4.9-8.8 4.9-4.2 0-9.1-2.3-9.1-11.6V24.6h4.8v14.6c0 5 1.5 8.4 5.9 8.4 3.2 0 5.5-2.2 6.3-4.4.3-.7.4-1.6.4-2.5V24.6h4.8v19.2zM67.3 32.8c0-3.1-.1-5.8-.2-8.2h4.2l.2 5.2h.2c1.2-3.5 4.1-5.8 7.3-5.8.5 0 .9.1 1.4.2v4.5c-.5-.1-1-.2-1.6-.2-3.4 0-5.8 2.6-6.5 6.2-.1.7-.2 1.4-.2 2.2V51h-4.8V32.8zM95.4 51L86 14.2h5l4.4 18.6c1.1 4.6 2.1 9.2 2.7 12.7h.1c.6-3.7 1.8-8 3-12.8l4.9-18.5h5l4.5 18.7c1 4.4 2 8.7 2.6 12.6h.1c.8-4 1.8-8.1 3-12.7l4.9-18.5h4.9L120.6 51h-5L111 31.9c-1.1-4.7-1.9-8.3-2.4-12h-.1c-.7 3.7-1.5 7.3-2.8 12L100.4 51h-5zM154.9 37.6c0 9.8-6.8 14-13.2 14-7.2 0-12.7-5.2-12.7-13.6 0-8.8 5.8-14 13.1-14 7.7 0 12.8 5.5 12.8 13.6zm-21 .3c0 5.8 3.3 10.1 8 10.1 4.6 0 8-4.3 8-10.3 0-4.5-2.2-10.1-7.9-10.1s-8.1 5.2-8.1 10.3zM158.2 32.8c0-3.1-.1-5.8-.2-8.2h4.2l.2 5.2h.2c1.2-3.5 4.1-5.8 7.3-5.8.5 0 .9.1 1.4.2v4.5c-.5-.1-1-.2-1.6-.2-3.4 0-5.8 2.6-6.5 6.2-.1.7-.2 1.4-.2 2.2V51h-4.8V32.8zM173.5 12.3h4.8V51h-4.8V12.3zM206.5 12.3v31.9c0 2.3.1 5 .2 6.8h-4.3l-.2-4.6h-.2c-1.5 2.9-4.7 5.2-9 5.2-6.4 0-11.3-5.4-11.3-13.4-.1-8.8 5.4-14.2 11.9-14.2 4 0 6.8 1.9 8 4h.1V12.3h4.8zm-4.8 23.1c0-.6-.1-1.4-.2-2a7 7 0 00-6.9-5.6c-5 0-7.9 4.4-7.9 10.2 0 5.3 2.6 9.8 7.8 9.8 3.2 0 6.2-2.1 7.1-5.7.2-.7.2-1.3.2-2.1v-4.6zM42.8 64c.1 1.6-1.1 2.9-3.1 2.9-1.7 0-2.9-1.3-2.9-2.9 0-1.7 1.3-3 3-3 1.9 0 3 1.3 3 3zm-5.4 33.8V71.4h4.8v26.4h-4.8zM47.5 78.6c0-2.7-.1-5-.2-7.1h4.3l.3 4.4h.1c1.3-2.5 4.4-5 8.8-5 3.7 0 9.4 2.2 9.4 11.2v15.8h-4.8V82.6c0-4.3-1.6-7.8-6.1-7.8-3.2 0-5.6 2.2-6.5 4.9-.2.6-.3 1.4-.3 2.2v15.9h-4.8V78.6zM84 61.6c2.9-.4 6.3-.8 10.1-.8 6.8 0 11.7 1.6 14.9 4.6 3.3 3 5.2 7.3 5.2 13.2 0 6-1.9 10.9-5.3 14.3-3.4 3.4-9.1 5.3-16.3 5.3-3.4 0-6.2-.2-8.6-.4V61.6zm4.8 32.5c1.2.2 3 .3 4.8.3 10.2 0 15.7-5.7 15.7-15.6.1-8.7-4.9-14.2-14.9-14.2-2.5 0-4.3.2-5.6.5v29zM132.1 97.8l-.4-3.3h-.2a9.79 9.79 0 01-8.1 3.9c-5.4 0-8.1-3.8-8.1-7.6 0-6.4 5.7-9.9 15.9-9.8v-.5c0-2.2-.6-6.1-6-6.1-2.5 0-5 .8-6.9 2l-1.1-3.2c2.2-1.4 5.4-2.3 8.7-2.3 8.1 0 10.1 5.5 10.1 10.8v9.9c0 2.3.1 4.5.4 6.3h-4.3zm-.7-13.4c-5.3-.1-11.2.8-11.2 5.9 0 3.1 2.1 4.6 4.5 4.6 3.4 0 5.6-2.2 6.4-4.4.2-.5.3-1 .3-1.5v-4.6zM146.6 63.9v7.6h6.9v3.7h-6.9v14.2c0 3.3.9 5.1 3.6 5.1 1.3 0 2.2-.2 2.8-.3l.2 3.6c-.9.4-2.4.7-4.3.7-2.2 0-4-.7-5.2-2-1.4-1.4-1.9-3.8-1.9-6.9V75.1h-4.1v-3.7h4.1v-6.3l4.8-1.2zM171.4 97.8l-.4-3.3h-.2a9.79 9.79 0 01-8.1 3.9c-5.4 0-8.1-3.8-8.1-7.6 0-6.4 5.7-9.9 15.9-9.8v-.5c0-2.2-.6-6.1-6-6.1-2.5 0-5 .8-6.9 2l-1.1-3.2c2.2-1.4 5.4-2.3 8.7-2.3 8.1 0 10.1 5.5 10.1 10.8v9.9c0 2.3.1 4.5.4 6.3h-4.3zm-.7-13.4c-5.3-.1-11.2.8-11.2 5.9 0 3.1 2.1 4.6 4.5 4.6 3.4 0 5.6-2.2 6.4-4.4.2-.5.3-1 .3-1.5v-4.6z"/></g></g></a></g><a href="https://ourworldindata.org/grapher/share-of-cancer-deaths-attributed-to-risk-factors" target="_blank"><text font-size="27" x="15" y="36.6" fill="#555"><tspan x="15" y="36.6">Share of cancer deaths attributed to risk factors, 2016</tspan></text></a><text font-size="14.4" x="15" y="55.5" fill="#666"><tspan x="15" y="55.52">Global share of cancer deaths are attributed to the range of linked risk factors. These include known risks such as</tspan><tspan x="15" y="71.36">smoking, diet and nutrition, obesity, physical inactivity, alcohol consumption, air pollution, and environmental</tspan><tspan x="15" y="87.2">exposures. Sun exposure (linked to skin cancer) is not included in IHME estimates. The remaining share therefore</tspan><tspan x="15" y="103.04">represents deaths which would be expected to have occurred in the absence of any risk factors.</tspan></text></g><g class="DiscreteBarChart"><g class="HorizontalAxis" fill="#666" text-anchor="middle" font-size="16.2"><text x="252.2" y="556.5">0%</text><text x="359" y="556.5">20%</text><text x="465.9" y="556.5">40%</text><text x="572.8" y="556.5">60%</text><text x="679.6" y="556.5">80%</text><text x="786.5" y="556.5">100%</text></g><g class="AxisGridLines"><path stroke="#ccc" d="M252.2 535.3V124.9"/><path stroke="#ddd" stroke-dasharray="3,2" d="M359 535.3V124.9M465.9 535.3V124.9M572.8 535.3V124.9M679.6 535.3V124.9M786.5 535.3V124.9"/></g><g class="bar"><text x="247.15" y="130.98" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Cervical cancer</text><path fill="#a50026" opacity=".85" d="M252.2 124.9h534.3v12.16H252.2z"/><text x="791.5" y="130.98" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">100%</text></g><g class="bar"><text x="247.15" y="146.18" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Mesothelioma</text><path fill="#BE1827" opacity=".85" d="M252.2 140.1h488.4v12.16H252.2z"/><text x="745.6" y="146.18" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">91.4%</text></g><g class="bar"><text x="247.15" y="161.38" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Tracheal, bronchus, and lung cancer</text><path fill="#d73027" opacity=".85" d="M252.2 155.3h449.4v12.16H252.2z"/><text x="706.6" y="161.38" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">84.1%</text></g><g class="bar"><text x="247.15" y="176.58" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Larynx cancer</text><path fill="#E64F35" opacity=".85" d="M252.2 170.5h383.6v12.16H252.2z"/><text x="640.8" y="176.58" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">71.8%</text></g><g class="bar"><text x="247.15" y="191.78" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Lip and oral cavity cancer</text><path fill="#F98E52" opacity=".85" d="M252.2 185.7h372.9v12.16H252.2z"/><text x="630.1" y="191.78" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">69.8%</text></g><g class="bar"><text x="247.15" y="206.98" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Esophageal cancer</text><path fill="#f46d43" opacity=".85" d="M252.2 200.9h372.9v12.16H252.2z"/><text x="630.1" y="206.98" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">69.8%</text></g><g class="bar"><text x="247.15" y="222.18" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Nasopharynx cancer</text><path fill="#fdae61" opacity=".85" d="M252.2 216.1h341.9v12.16H252.2z"/><text x="599.1" y="222.18" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">64%</text></g><g class="bar"><text x="247.15" y="237.38" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Colon and rectum cancer</text><path fill="#FEC776" opacity=".85" d="M252.2 231.3h284.2v12.16H252.2z"/><text x="541.4" y="237.38" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">53.2%</text></g><g class="bar"><text x="247.15" y="252.58" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Liver cancer</text><path fill="#fee08b" opacity=".85" d="M252.2 246.5h221.7v12.16H252.2z"/><text x="478.9" y="252.58" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">41.5%</text></g><g class="bar"><text x="247.15" y="267.78" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Uterine cancer</text><path fill="#FFF0A5" opacity=".85" d="M252.2 261.7h195v12.16h-195z"/><text x="452.2" y="267.78" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">36.5%</text></g><g class="bar"><text x="247.15" y="282.98" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Kidney cancer</text><path fill="#ffffbf" opacity=".85" d="M252.2 276.9h172.6v12.16H252.2z"/><text x="429.8" y="282.98" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">32.3%</text></g><g class="bar"><text x="247.15" y="298.18" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Bladder cancer</text><path fill="#ECF7A5" opacity=".85" d="M252.2 292.1h170.9v12.16H252.2z"/><text x="428.1" y="298.18" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">32%</text></g><g class="bar"><text x="247.15" y="313.38" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Pancreatic cancer</text><path fill="#d9ef8b" opacity=".85" d="M252.2 307.3h146.9v12.16H252.2z"/><text x="404.1" y="313.38" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">27.5%</text></g><g class="bar"><text x="247.15" y="328.58" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Breast cancer</text><path fill="#C0E47B" opacity=".85" d="M252.2 322.5h143.2v12.16H252.2z"/><text x="400.4" y="328.58" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">26.8%</text></g><g class="bar"><text x="247.15" y="343.78" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Stomach cancer</text><path fill="#a6d96a" opacity=".85" d="M252.2 337.7h98.3v12.16h-98.3z"/><text x="355.5" y="343.78" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">18.4%</text></g><g class="bar"><text x="247.15" y="358.98" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Gallbladder and biliary tract cancer</text><path fill="#96D269" opacity=".85" d="M252.2 352.9h80.1v12.16h-80.1z"/><text x="337.3" y="358.98" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">15%</text></g><g class="bar"><text x="247.15" y="374.18" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Leukemia</text><path fill="#86CB67" opacity=".85" d="M252.2 368.1h79v12.16h-79z"/><text x="336.2" y="374.18" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">14.8%</text></g><g class="bar"><text x="247.15" y="389.38" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Ovarian cancer</text><path fill="#76C465" opacity=".85" d="M252.2 383.3h65.7v12.16h-65.7z"/><text x="322.9" y="389.38" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">12.3%</text></g><g class="bar"><text x="247.15" y="404.58" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Thyroid cancer</text><path fill="#66bd63" opacity=".85" d="M252.2 398.5h50.2v12.16h-50.2z"/><text x="307.4" y="404.58" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">9.4%</text></g><g class="bar"><text x="247.15" y="419.78" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Multiple myeloma</text><path fill="#53B45F" opacity=".85" d="M252.2 413.7h36.3v12.16h-36.3z"/><text x="293.5" y="419.78" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">6.8%</text></g><g class="bar"><text x="247.15" y="434.98" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Non-Hodgkin lymphoma</text><path fill="#40AB5A" opacity=".85" d="M252.2 428.9h27.2v12.16h-27.2z"/><text x="284.4" y="434.98" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">5.1%</text></g><g class="bar"><text x="247.15" y="450.18" fill="#666" dominant-baseline="middle" text-anchor="end" font-size="13.5">Prostate cancer</text><path fill="#2DA255" opacity=".85" d="M252.2 444.1h23.5v12.16h-23.5z"/><text x="280.7" y="450.18" fill="#666" dominant-baseline="middle" text-anchor="start" font-size="13.5">4.4%</text></g><g class="bar" fill="#666" dominant-baseline="middle" font-size="13.5"><text x="247.15" y="465.38" text-anchor="end">Hodgkin lymphoma</text><text x="257.2" y="465.38" text-anchor="start">0%</text></g><g class="bar" fill="#666" dominant-baseline="middle" font-size="13.5"><text x="247.15" y="480.58" text-anchor="end">Brain and nervous system cancer</text><text x="257.2" y="480.58" text-anchor="start">0%</text></g><g class="bar" fill="#666" dominant-baseline="middle" font-size="13.5"><text x="247.15" y="495.78" text-anchor="end">Testicular cancer</text><text x="257.2" y="495.78" text-anchor="start">0%</text></g><g class="bar" fill="#666" dominant-baseline="middle" font-size="13.5"><text x="247.15" y="510.98" text-anchor="end">Non-melanoma skin cancer</text><text x="257.2" y="510.98" text-anchor="start">0%</text></g><g class="bar" fill="#666" dominant-baseline="middle" font-size="13.5"><text x="247.15" y="526.18" text-anchor="end">Malignant skin melanoma</text><text x="257.2" y="526.18" text-anchor="start">0%</text></g></g><g class="SourcesFooter" fill="#777"><g class="clickable" fill="#777"><text font-size="12.6" x="15" y="581.6"><tspan x="15" y="581.58">Source: IHME, Global Burden of Disease</tspan></text></g><text font-size="12.6" x="649" y="581.6"><tspan x="649.02" y="581.58"><a target="_blank" href="https://ourworldindata.org" fill="#777">OurWorldInData.org</a> • <a href="http://creativecommons.org/licenses/by-sa/4.0/deed.en_US" target="_blank" fill="#777">CC BY-SA</a></tspan></text></g></g></svg>